Leukemia & Lymphoma Society of Canada's Travel to Treatment Study Questionnaire |
INTRODUCTION PAGE 1
You are invited to participate in a research study about the impact of the need to travel for cancer treatment. This study is being conducted by Colleen McMillan at the Leukemia & Lymphoma Society of Canada. This introduction will help you make an informed decision regarding your participation in the study. This introduction will also explain what the study is about, the potential risks and benefits of participating, and your rights as a participant. If you do not understand something within this introduction, please contact the principal researcher:
Colleen McMillan
Advocacy Lead, The Leukemia & Lymphoma Society of Canada
colleen.mcmillan@lls.org or 1-647-253-5547
This study has been reviewed and received ethics clearance through a Research Ethics Board (REB). If you have questions for the Board, contact the Canadian SHIELD Ethics Review Board at 1-905-681-8661 (Canada and USA), or by E-mail at admin@cserb.com
If you are experiencing technical issues when completing the survey, please contact the Statistical Consulting and Survey Research Unit at: scsruccinb@uwaterloo.ca
Please complete this survey by January 10, 2025 to ensure your input is included.